This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Tirzepatide leads to 15.7 percent weight loss in overweight/obese adults with type 2 diabetes in SURMOUNT-2

Tirzepatide leads to 15.7 percent weight loss in overweight/obese adults with type 2 diabetes in...

USA: Findings from SURMOUNT-2 trial showed that overweight/obese adults with type 2 diabetes taking 15 mg of the once-weekly tirzepatide (Mounjaro)...
View All

Latest News and Guidelines

Nighttime hypoglycemia under diagnosed in elderly with insulin-treated type 2 diabetes

Nighttime hypoglycemia under diagnosed in elderly with insulin-treated type 2 diabetes

An hour long endoscopic procedure could eliminate need for insulin for type 2 diabetes

An hour long endoscopic procedure could eliminate need for insulin for type 2 diabetes

Longer midday naps may raise risk of obesity, metabolic syndrome, and high BP

Longer midday naps may raise risk of obesity, metabolic syndrome, and high BP

Diabeloop control algorithm integrated in an external device improves glycemic control in type 1 diabetes patients

Diabeloop control algorithm integrated in an external device improves glycemic control in type 1...

Increased HbA1c and HOMA-IR may predict risk of gestational diabetes early in pregnancy

Increased HbA1c and HOMA-IR may predict risk of gestational diabetes early in pregnancy

Promising new oral delivery mode may one day replace insulin injection for diabetes patients

Promising new oral delivery mode may one day replace insulin injection for diabetes patients

View All
X